← Back to Search

Stem Cell Therapy

Hair regrowth by SCE for Alopecia Areata

Phase 2
Recruiting
Research Sponsored by Throne Biotechnologies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hair regrowth will be evaluated at different time points post receiving stem cell educator therapy in 1, 3, and 6 months.
Awards & highlights

Study Summary

This trial will explore the use of stem cell therapy in combination with oral minoxidil to treat alopecia areata, a common autoimmune disease that results in loss of body hair.

Eligible Conditions
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hair regrowth will be evaluated at different time points post receiving stem cell educator therapy in 1, 3, and 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and hair regrowth will be evaluated at different time points post receiving stem cell educator therapy in 1, 3, and 6 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The percentage change in scalp hair growth.
Secondary outcome measures
Efficacy of modulation of autoimmune-related memory T-cell markers
Feasibility of SCE therapy
Preliminary efficacy of SCE therapy

Trial Design

2Treatment groups
Experimental Treatment
Group I: Minoxidil therapyExperimental Treatment1 Intervention
Control subjects will receive treatment with topical 5% minoxidil
Group II: Hair regrowth by SCEExperimental Treatment1 Intervention
AA subjects will receive Stem Cell Educator therapy. Hair regrowth will be evaluated during six-month follow-up studies.

Find a Location

Who is running the clinical trial?

Throne Biotechnologies Inc.Lead Sponsor
6 Previous Clinical Trials
320 Total Patients Enrolled
1 Trials studying Alopecia Areata
30 Patients Enrolled for Alopecia Areata
Hackensack Meridian HealthOTHER
131 Previous Clinical Trials
28,224 Total Patients Enrolled
Yale UniversityOTHER
1,848 Previous Clinical Trials
2,737,798 Total Patients Enrolled
5 Trials studying Alopecia Areata
59 Patients Enrolled for Alopecia Areata

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are actively engaged in this research?

"Indeed, the information on clinicaltrials.gov confirms that this scientific endeavour is still in its active recruitment phase. The study was first announced on September 20th 2022 and recently updated November 10th of the same year. Researchers are actively searching for 20 participants from a total of 3 trial centres."

Answered by AI

What can be gleaned from previous research on the pairing of Stem Cell Educator therapy and minoxidil?

"Initially researched at Wake Forest Baptist Health Department of Dermatology, the combination of minoxidil and Stem Cell Educator therapy has been tested across 28 distinct clinical trials as of 2021. Currently, 5 additional studies are recruiting participants; many in Hackensack, Connecticut."

Answered by AI

What risks are associated with using Stem Cell Educator therapy alongside minoxidil for medical treatment?

"The safety of the combination therapy consisting of Stem Cell Educator and minoxidil is rated at a 2, as there are some clinical studies that provide evidence for its security but none attesting to its efficacy."

Answered by AI

Is this investigation currently open to new participants?

"The medical trial is still on the lookout for volunteers, as indicated by its most recent update occurring on November 10th 2022. The original posting of this study was made on September 20th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Florida
New Jersey
Texas
Other
How old are they?
18 - 65
What site did they apply to?
Hackensack Meridian Health
Throne Biotechnologies
Yale University School of Medicine
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I need help going my hair back. This disease has burdened me for so long. It has gave me severe depression and anxiety throughout the years. Current treatments are not ideal and come with a price. I believe in the power of stem cells and would be thrilled to try a new therapy.
PatientReceived no prior treatments
I have been burdened with this since I was 12 years old and have spent countless hours and dollars trying to feel normal and healthy. I have tried steroids, minoxidil, PRP, squaric acid. I recently tried Olumiant which worked and then all of the sudden stopped working and I lost everything again. I am desperate to have my life back.
PatientReceived 2+ prior treatments

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Throne Biotechnologies: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
~8 spots leftby Apr 2025